T. Rowe Price Associates »

Hillevax shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Hillevax (HLVX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Hillevax

Tip: Access up to 7 years of quarterly data

All positions including Hillevax held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hillevax by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $18k 10k 1.79
2024-06-30 $146k 10k 14.51

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Hillevax

Frazier Life Sciences Management
Tang Capital Management
BlackRock
BlackRock
Franklin Resources
Deerfield Management Company
Carlyle
Deep Track Capital
Vanguard Group
Henderson Group
Braidwell
StepStone
Samsara BioCapital
MPM Oncology Impact Management
Geode Capital Management

View all funds holding Hillevax